Reports say the Trump administration may let some compounding pharmacies dispense peptides not fully safety tested, and an Auckland academic is concerned.
Recap by typeshit. Post by Facebook on Facebook.
A local TV health segment on safety when using peptide therapy and GLP-1 drugs, aimed at men's health.
A Williamsburg shop sells injectable peptide vials for around $95 each, while the FDA has sent warning letters to sellers relying on the same label.
9:07
The endocrinologist takes on whether people can get retatrutide now, setting gray market supply against the results from Lilly's actual trials.
UW Medicine notes that many of these experimental peptides have not been regulated by the FDA, and some have never been tested in people.
AFRO News reports that while GLP-1 drugs help with weight and diabetes, losing weight quickly may also reduce muscle and bone, and doctors are urging patients to take care.
The NHS says it knows some people are getting hold of retatrutide for weight loss and reminds them the trial drug has no license or approval.
Loading…